Skip to main content
Caplight Logo









AATec Medical GmbH

AATec Medical GmbH

Private
PlaneggHealthcare & Life Scienceshttps://aatec-medical.com/

Last Round

Series A

Apr 15, 2025

Total Funding Raised

$7.52M

Company Overview

AATec Medical GmbH is a biotechnology company developing a product platform based on recombinant alpha-1 antitrypsin (AAT) for the treatment of respiratory inflammatory diseases, airway infections and rare diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials, Medical Devices

Business Model

B2B

Customer Profile

Revenue Share, Services & Consulting

AI Layer

Non-AI

Keywords

recombinant alpha-1 antitrypsinAATinhaled therapeuticrespiratory disease treatmentbiologic drug developmentpulmonary drug deliveryrecombinant proteinpreclinical biotechinflammatory lung diseasenon-cystic fibrosis bronchiectasisNCFBacute respiratory distress syndromeARDSnebulizerorgan-on-chiplung-on-a-chipprotein engineering

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

AATec Medical GmbH Comparables

Compare AATec Medical GmbH with similar companies based on industry and business-model similarity.

AATec Medical GmbH comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
ReCode Therapeutics
63%
Takeda
63%
Adverum Biotechnologies Inc
62%

AATec Medical GmbH Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AApr 15, 2025
SeedJul 17, 2023

Key People

Founding team and executive leadership

Rüdiger Jankowsky

Co-founder & CEO

Founding Team

AATec Medical GmbH Investors

Notable investors and investment history

AATec Medical GmbH investors
InvestorRounds
SPRINDSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Sep 2, 2025

    Grew 50% QoQ from 6 to 9 employees.

  • Apr 15, 2025

    $4.5M round led by SPRIND

AATec Medical GmbH Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

AATec Medical GmbH Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about AATec Medical GmbH's valuation, stock price, and market status.

Firmographic Details

HeadquartersPlanegg
Employee Range8
Year Founded2021
Last FundingApr 15, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?